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Abstract 
 
Baculoviruses are lytic insect viruses. Upon internalisation, the viral genome orchestrates a sequential 
expression process ultimately leading to lysis of the infected cell. Release of progeny capable of 
infecting other cells during the process completes the infection cycle. Studies of the infection cycle in 
cell culture are typically conducted by synchronous infection, i.e. near simultaneous infection of all 
cells, by means of high virus concentrations. The behaviour of the synchronously infected culture, 
such as the timing of onset of progeny release, is considered representative for the infection 
progression within individual cells. In reality, however, the synchronously infected culture only 
reflects the average behaviour of all infected cells. The infection progresses in individual cells display 
large variability; this is most obvious in the observation that within the same culture some cells 
undergo cell lysis at two days post infection while others remain viable up to four days post infection. 
Such variabilities or asynchronies observed in synchronously infected culture is the topic of this 
thesis. 
 
Using a simple phenomenological model, it is demonstrated that cell death and associated intracellular 
product release is adequately described assuming that the waiting time from infection to cell death 
follows a Gaussian distribution with a mean of 59 hours post infection (hpi) and a standard deviation 
of 15hpi. Unlike other deterministic model developed over the last decade (Licari and Bailey 1992; 
Nielsen 2000), this stochastic model does not make the biologically inconsistent assumption that cells 
continue to be metabolically active following loss of membrane integrity. While elegant in its 
simplicity, the model provides no explanation for the underlying stochasticity. Investigations into the 
cause of this dispersion of cell death highlighted further asynchronies in the specific recombinant 
protein yield, in viral DNA content, in virus budding rate, and in cell volume increase instead of 
clarifying the issue. 
 
A modelling framework developed by Licari & Bailey (1992) and later Hu & Bentley (2000) 
incorporates the number of infectious particles each individual cell receives as a possible source of the 
dispersions in the host cell responses. However, this was found NOT to be the cause of the observed 
asynchronies under non-substrate limiting conditions. The timing of cell death, cell volume increase, 
recombinant product yield, viral DNA content, and virus budding rate is identical in Sf9 cell cultures 
infected at multiplicities of infection of ~5, ~15, and ~45 infectious particles per cell. 
 
Cell cycle variation has previously been suggested as a possible cause for observed asynchronies in 
baculovirus infections (Brown and Faulkner, 1975). The cell cycle phase is indirectly linked to the 
cell volume, because a G2-phase cell prior to division is inherently twice the cell volume of a G1-
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phase cell after cell division. By the same logic, it is also apparent that a G2-phase cell possesses twice 
the number of ribosomes of a G1-phase cell and thus a doubled protein production capacity. The effect 
of the cell cycle or cell volume on the baculovirus infection was determined by splitting an 
exponentially growing Sf9 cell culture into 5 cell size dependent fractions by centrifugal elutriation. 
The subsequent infection of these fractions showed (1) no dependency of the timing of cell lysis and 
cell volume increase and (2) approximately twofold increase of a) recombinant protein yield, b) viral 
DNA concentration, and c) budded virus yield. The recombinant protein yield showed a strong 
proportionality to the initial cell volume and the total RNA concentration during the late phase of the 
infection. As argued in chapter 6, these proportionalities suggest that the observed differences in the 
responses of the cell fractions to the baculovirus infection are more likely caused by the difference in 
the protein production capacity than by cell cycle specific molecules. 
 
This investigation gave also reason to speculate that infected cells cannot progress beyond the G2/M 
phase, and cell cycle progression continues undisturbed until ~8hpi when all cellular DNA replication 
appears to cease. Resuspended, infected Sf9 cells synchronised by centrifugal elutriation showed an 
identical cell cycle distribution as the non-infected control cultures for the first ~8hpi; G1 and G2/M 
phase cell proportions remained unchanged, whereas S phase cells progress to G2/M phase. 
Subsequently, the non-infected control cells resumed normal cycling whereas all infected cells 
remained at the same cell cycle phase from 8 to 11hpi. The initial cell cycle arrests in G2/M phase in 
both infected and non-infected cultures were caused through medium exchange. 
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Prologue 
 
There is a wealth of information about baculovirus (Granados and Federici 1986; McIntosh 1994; 
Shuler 1995; Vlak, De Gooijer et al. 1996; Miller 1997; Ikonomou, Schneider et al. 2003). Here, I hint 
only at a few selected corner stones where the baculovirus has its relevance. 
People have been aware of the effects of baculoviruses for centuries and written accounts go back to 
ancient Chinese texts describing silkworm culture. Research during the first half of the 20th century 
established that virus particles were present in the observed polyhedral crystals that cause the ‘wilting 
disease’ of insects, and the view that baculoviruses were important in the natural control of insect 
populations was advanced. In 1975, the first baculovirus was registered as a pesticide in the United 
States. The main advantage of this virus as a pesticide is its small impact on the environment due to 
its narrow host range and niche markets are currently supplied by in-vivo produced wild-type viruses. 
Its main disadvantages compared to chemical pesticides are the delayed lethality of the virus and the 
production costs. Hopes to cost effectively produce the virus in-vitro have been severely diminished 
during the 1990’s due to the in-vitro selection for mutants that are inactive in agricultural applications; 
however, a few scattered groups still pursue this goal – among them ours. In order to overcome the 
delayed lethality, insect toxin expressing recombinant baculoviruses have been tested, but the 
commercialisation of these viruses has failed so far because they can only be produced in an in-vitro 
process which is currently not financially viable. 
The development of baculoviruses as biological pesticide stimulated efforts to understand the 
molecular biology of the virus. The Autographa californica multiple nuclear polyhedrosis virus 
(AcMNPV) became the focus of much of the research because of its ease of propagation, relative 
stability, and relative broad host range. The realisation that there were two different forms of the 
baculovirus, a budded virus and a virus that was occluded in an abundantly expressed matrix protein 
called polyhedrin, was important in understanding its pathology. The budded form is responsible for 
the spread of the infection through the tissues of the insect, and the occluded form for the spread 
between insects through oral ingestion. The spread of the virus within cell culture relies exclusively 
on the budded form, which leaves the polyhedrin (polh) promoter free to allow high level expression 
of recombinant proteins. Various baculovirus expression vector systems1 (BEVS), commonly based 
on the AcMNPV, on the market utilise this approach. The advantages of the BEVS over other 
expression systems is that it often yields high protein concentrations with little process optimisation, 
allows for post translational modification, its construction is commonly faster than mammalian 
expression system, and insect cell cultivation is simpler than mammalian culture. The recent 
popularity of the BEVS for the expression of protein at research stage and for diagnostic purposes is 
grounded in these advantages. Its main shortcoming is that the insect glycosylation pattern is often 
                                                 
1 The BEV refers to the vector only, whereas the BEVS refers to the BEV – cell system. 
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less suitable for therapeutic or crystallographic applications than mammalian patterns. This issue has 
recently been addressed by the construction of insect cell lines that produce more mammalian like 
glycosylation, but there has been little experience with these cell lines yet. The second big 
disadvantage of the BEVS is the lack of experience in large scale production compared to extensive 
research and development activities in large scale mammalian cell culture over the last 15 to 20 years. 
The baculovirus might be used in large scale production, if in the next few years the in-vitro mutation 
problem in the pesticide production can be overcome and the medium requirement for high density 
infections can be met in a cost effective way. If not, the BEVS will remain a useful tool for the fast 
production of small amounts of glycosylated proteins until it is replaced by more effective 
alternatives. In either case, baculovirus research has provided exciting insight into fundamental 
principles such as apoptosis and generic viral infection behaviour. A continued effort in improving 
our insight into the mechanisms of the baculovirus infection kinetics will eventually lead to improved 
production schemes and reveal biological principles that reach far beyond this virus. Mathematical 
modelling allows for the rational design of production processes and offers a frame of reference that 
guides to considerations which may have been overlooked otherwise. It is in this light the presented 
work has been conducted, and it is modelling that highlights the variability in cell responses to the 
baculovirus infection. 
 
 
 
